R&D | November 14, 2025
UK MHRA finds gut microbiome research unreliable across labs
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
FIBROSARC did not meet its primary PFS endpoint in the final analysi
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
Moraine will serve as OTSAW’s exclusive distributor in Japan, deploying the Camello+ autonomous mobile robot and TransCar autonomous guided vehicle to support hospital logistics
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Enabling a new era in minimally invasive obesity treatment across Europe
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
Venus Remedies now has 29 active product approvals in Vietnam alone
The said inspection concluded with Zero Form 483 observation
Subscribe To Our Newsletter & Stay Updated
